Artificial intelligence- and quantum mechanics-based capabilities to Design, Make, Test, and Analyse novel pharmaceuticals
Pending.ai is an artificial intelligence company offering software for the designing, making, and testing drugs to treat disease that is headquartered in WollongongWollongong, Australia and was founded in 2018 by Jingjing Guo and Mark Waller. The Pending.ai platform is made to augment the cognitive abilities of individual scientists and research teams using the company's artificial intelligence models based on high-quality evidence-based drug design solutions.